In animal experiment studies, Chinese researchers have found that a metabolite of the antiviral drug Remdesivir called GS-441524 could help inhibit the severe acute respiratory syndrome coronavirus 2 ...
SAN DIEGO, May 20, 2014 (BUSINESS WIRE) -- Gilead Sciences, Inc. GILD +0.65% today announced results from a placebo-controlled, Phase 2a challenge study in healthy adult patients intranasally infected ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
A multicentre, open-label phase II study of irinotecan, capecitabine, and oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) ...
A phase II trial of neoadjuvant chemotherapy with docetaxel/cisplatin/capecitabine in thoracic esophageal squamous cell carcinoma. Background: GS-5745 is a monoclonal ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Gilead Sciences is currently conducting a ...
Activists are calling on the pharmaceutical firm Gilead Sciences to study a drug for the treatment of Covid-19 that showed promise in curing cats of a coronavirus. The drug, called GS-441524, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results